Vann Equity Management’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$319K Hold
2,238
– – 0.19% 124
2026
Q2
$351K Buy
2,238
+7
+0.3% +$1.05K 0.21% 113
2026
Q1
$341K Buy
+2,231
New +$342K 0.24% 108

Other funds holding NVS

Vann Equity Management's NVS Position: Q3 2026 in Review

Vann Equity Management held its Novartis (NVS) position steady in Q3 2026 at 2,238 shares worth $319K. The position accounts for 0.19% of the portfolio, ranked #124.

Vann Equity Management first reported a position in NVS in Q1 2026 and has held it in 3 quarters since. The position peaked at $351K in Q2 2026. 1,554 funds tracked by Wall St. Rank hold NVS as of Q3 2026.

  • Vann Equity Management held 2,238 shares of Novartis worth $319K as of Q3 2026.
  • Vann Equity Management left its Novartis share count unchanged in Q3 2026.
  • Novartis made up 0.19% of Vann Equity Management's portfolio in Q3 2026, its #124 holding.
  • Vann Equity Management first reported a position in Novartis in Q1 2026 and has held it in 3 quarters since.
  • Vann Equity Management's Novartis position peaked at $351K in Q2 2026.
  • 1,554 funds tracked by Wall St. Rank held Novartis as of Q3 2026.

Based on Vann Equity Management's 13F filing for Q3 2026, filed 8 Oct 2026.